These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31733719)

  • 1. Utilization of Biomarkers in Lupus Nephritis.
    Caster DJ; Powell DW
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):351-359. PubMed ID: 31733719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in lupus nephritis.
    Sharafaldin ENK; Sim MS; Lim SK; Alhussieni K; Huri HZ
    Clin Chim Acta; 2024 Aug; 562():119894. PubMed ID: 39068963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of urine: implications for lupus nephritis.
    Aljaberi N; Bennett M; Brunner HI; Devarajan P
    Expert Rev Proteomics; 2019 Apr; 16(4):303-313. PubMed ID: 30855196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in lupus nephritis: can biomarkers get us there?
    Caster DJ; Merchant ML; Klein JB; Powell DW
    Transl Res; 2018 Nov; 201():26-39. PubMed ID: 30179587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Forward With Biologics in Lupus Nephritis.
    Hobeika L; Ng L; Lee IJ
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):338-350. PubMed ID: 31733718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in lupus nephritis.
    Misra R; Gupta R
    Int J Rheum Dis; 2015 Feb; 18(2):219-32. PubMed ID: 25884459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of SLE Nephritis in the Era of Precision Medicine.
    Regunathan-Shenk R; Radhakrishnan J
    Curr Rheumatol Rev; 2018; 14(2):140-144. PubMed ID: 27426406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
    Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
    Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
    Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
    Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
    J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cell-free urine MicroRNA with lupus nephritis in children.
    Abulaban KM; Fall N; Nunna R; Ying J; Devarajan P; Grom A; Bennett M; Ardoin SP; Brunner HI
    Pediatr Rheumatol Online J; 2016 Jan; 14(1):4. PubMed ID: 26762103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Lupus Nephritis: Looking for a New Vision.
    Morales E; Galindo M; Trujillo H; Praga M
    Nephron; 2021; 145(1):1-13. PubMed ID: 33147587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of miR-21 and miR-155 in peripheral blood mononuclear cells as potential biomarkers for lupus nephritis.
    Khoshmirsafa M; Kianmehr N; Falak R; Mowla SJ; Seif F; Mirzaei B; Valizadeh M; Shekarabi M
    Int J Rheum Dis; 2019 Mar; 22(3):458-467. PubMed ID: 30398001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis.
    Olivares D; Perez-Hernandez J; Forner MJ; Perez-Soriano C; Tormos MC; Saez GT; Chaves FJ; Redon J; Cortes R
    Clin Sci (Lond); 2018 Mar; 132(5):569-579. PubMed ID: 29440621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of proliferative and membranous lupus nephritis: review of key clinical trials.
    Alshayeb H; Wall BM; Gosmanova EO
    Am J Med Sci; 2012 Jan; 343(1):86-90. PubMed ID: 21685786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil involvement in lupus nephritis: a basis for innovation in daily care.
    Charles N; Chemouny JM; Daugas E
    Nephrol Dial Transplant; 2019 May; 34(5):750-756. PubMed ID: 31009949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.